リコンビナント
RabMAb

Anti-MAPK6 抗体 [EP1720Y] (ab53277)

ab53277 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab53277 は 6 報の論文で使用されています。

  • Ling S  et al. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1. J Hematol Oncol 10:59 (2017). PubMed: 28241849
  • Mathien S  et al. Deubiquitinating Enzyme USP20 Regulates Extracellular Signal-Regulated Kinase 3 Stability and Biological Activity. Mol Cell Biol 37:N/A (2017). IP ; Human . PubMed: 28167606
  • Marquis M  et al. The non-classical MAP kinase ERK3 controls T cell activation. PLoS One 9:e86681 (2014). WB ; Mouse . PubMed: 24475167
  • Long W  et al. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. J Clin Invest 122:1869-80 (2012). WB, IP . PubMed: 22505454
  • Déléris P  et al. Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway. J Biol Chem 286:6470-8 (2011). PubMed: 21177870
  • Chang AH  et al. Iron Regulatory Protein 2 Turnover through a Nonproteasomal Pathway. J Biol Chem 286:23698-707 (2011). WB ; Human . PubMed: 21558272

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録